3,4-Dihydroxybenzoate

Details

Top
Internal ID f91a1353-19b0-45c4-aff7-537e15addabd
Taxonomy Benzenoids > Benzene and substituted derivatives > Benzoic acids and derivatives > Hydroxybenzoic acid derivatives
IUPAC Name 4-carboxy-2-hydroxyphenolate
SMILES (Canonical) C1=CC(=C(C=C1C(=O)O)O)[O-]
SMILES (Isomeric) C1=CC(=C(C=C1C(=O)O)O)[O-]
InChI InChI=1S/C7H6O4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H,(H,10,11)/p-1
InChI Key YQUVCSBJEUQKSH-UHFFFAOYSA-M
Popularity 72 references in papers

Physical and Chemical Properties

Top
Molecular Formula C7H5O4-
Molecular Weight 153.11 g/mol
Exact Mass 153.01878364 g/mol
Topological Polar Surface Area (TPSA) 80.60 Ų
XlogP 1.80
Atomic LogP (AlogP) 0.16
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
1ykp
NSC16631
DB03946
4-10-00-01459 (Beilstein Handbook Reference)
SMR000528167
C00230
D-3487
2buv
4,5-dihydroxybenzoate
3,4-DHBA
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 3,4-Dihydroxybenzoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9169 91.69%
Caco-2 - 0.5935 59.35%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability + 0.7714 77.14%
Subcellular localzation Mitochondria 0.8402 84.02%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9507 95.07%
OATP1B3 inhibitior + 0.9395 93.95%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9867 98.67%
P-glycoprotein inhibitior - 0.9824 98.24%
P-glycoprotein substrate - 0.9863 98.63%
CYP3A4 substrate - 0.8035 80.35%
CYP2C9 substrate - 0.8086 80.86%
CYP2D6 substrate - 0.8832 88.32%
CYP3A4 inhibition - 0.9662 96.62%
CYP2C9 inhibition - 0.8921 89.21%
CYP2C19 inhibition - 0.9230 92.30%
CYP2D6 inhibition - 0.9546 95.46%
CYP1A2 inhibition - 0.9523 95.23%
CYP2C8 inhibition - 0.7662 76.62%
CYP inhibitory promiscuity - 0.9436 94.36%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.7538 75.38%
Carcinogenicity (trinary) Non-required 0.6670 66.70%
Eye corrosion + 0.5269 52.69%
Eye irritation + 1.0000 100.00%
Skin irritation + 0.8987 89.87%
Skin corrosion - 0.8581 85.81%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.9038 90.38%
Micronuclear + 0.7900 79.00%
Hepatotoxicity + 0.6750 67.50%
skin sensitisation + 0.6969 69.69%
Respiratory toxicity - 0.6000 60.00%
Reproductive toxicity + 0.7778 77.78%
Mitochondrial toxicity - 0.6375 63.75%
Nephrotoxicity - 0.5768 57.68%
Acute Oral Toxicity (c) III 0.5739 57.39%
Estrogen receptor binding - 0.8269 82.69%
Androgen receptor binding - 0.5658 56.58%
Thyroid receptor binding - 0.8454 84.54%
Glucocorticoid receptor binding - 0.6615 66.15%
Aromatase binding - 0.7999 79.99%
PPAR gamma - 0.7772 77.72%
Honey bee toxicity - 0.9728 97.28%
Biodegradation + 0.9500 95.00%
Crustacea aquatic toxicity - 0.8500 85.00%
Fish aquatic toxicity + 0.9389 93.89%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3194 P02766 Transthyretin 95.23% 90.71%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.81% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.44% 95.56%
CHEMBL1811 P34995 Prostanoid EP1 receptor 87.63% 95.71%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 86.56% 91.11%
CHEMBL3060 Q9Y345 Glycine transporter 2 85.62% 99.17%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 84.58% 93.40%
CHEMBL4208 P20618 Proteasome component C5 83.16% 90.00%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.13% 90.71%
CHEMBL4657 Q6V1X1 Dipeptidyl peptidase VIII 81.10% 97.21%

Cross-Links

Top
PubChem 54675866
NPASS NPC156655